|
2025-03-20 |
2025-03-18 |
S
Sale
|
ROWLAND LLOYD A
General Counsel
Officer
|
10,203
-7.8%
0.60
USD 6,112
|
10,203
-7.8%
|
0.60
|
USD 6,112
|
|
|
2025-03-20 |
2025-03-18 |
S
Sale
|
McCarthy Sean A.
CEO
Executive Director
|
37,656
-3.6%
0.60
USD 22,556
|
37,656
-3.6%
|
0.60
|
USD 22,556
|
|
|
2025-03-20 |
2025-03-18 |
S
Sale
|
BELVIN MARCIA
SVP, Chief Scientific Officer
Officer
|
19,512
-7.3%
0.60
USD 11,688
|
19,512
-7.3%
|
0.60
|
USD 11,688
|
|
|
2025-03-20 |
2025-03-18 |
S
Sale
|
Ogden Christopher
Chief Financial Officer
Officer
|
8,551
-4.1%
0.60
USD 5,122
|
8,551
-4.1%
|
0.60
|
USD 5,122
|
|
|
2025-03-20 |
2025-03-18 |
S
Sale
|
Chu Yu-Waye
Chief Medical Officer
Officer
|
4,025
-2.9%
0.60
USD 2,411
|
4,025
-2.9%
|
0.60
|
USD 2,411
|
|
|
2024-08-22 |
2024-08-20 |
S
Sale
|
Landau Jeffrey B
Chief Business Officer
Officer
|
4,181
-3.4%
1.23
USD 5,139
|
4,181
-3.4%
|
1.23
|
USD 5,139
|
|
|
2024-08-22 |
2024-08-20 |
S
Sale
|
McCarthy Sean A.
CEO
Executive Director
|
13,898
-2.1%
1.23
USD 17,082
|
13,898
-2.1%
|
1.23
|
USD 17,082
|
|
|
2024-08-22 |
2024-08-20 |
S
Sale
|
Ogden Christopher
Chief Financial Officer
Officer
|
1,984
-1.8%
1.23
USD 2,439
|
1,984
-1.8%
|
1.23
|
USD 2,439
|
|
|
2024-08-22 |
2024-08-20 |
S
Sale
|
ROWLAND LLOYD A
General Counsel
Officer
|
4,181
-3.1%
1.23
USD 5,139
|
4,181
-3.1%
|
1.23
|
USD 5,139
|
|
|
2024-08-22 |
2024-08-20 |
S
Sale
|
BELVIN MARCIA
SVP, Chief Scientific Officer
Officer
|
4,181
-2.3%
1.23
USD 5,139
|
4,181
-2.3%
|
1.23
|
USD 5,139
|
|
|
2024-03-21 |
2024-03-19 |
S
Sale
|
ROWLAND LLOYD A
General Counsel
Officer
|
5,268
-4.3%
2.09
USD 10,986
|
5,268
-4.3%
|
2.09
|
USD 10,986
|
|
|
2024-03-21 |
2024-03-19 |
S
Sale
|
BELVIN MARCIA
SVP, Chief Scientific Officer
Officer
|
12,795
-7.1%
2.09
USD 26,684
|
12,795
-7.1%
|
2.09
|
USD 26,684
|
|
|
2024-03-21 |
2024-03-19 |
S
Sale
|
Landau Jeffrey B
Chief Business Officer
Officer
|
6,562
-5.6%
2.09
USD 13,685
|
6,562
-5.6%
|
2.09
|
USD 13,685
|
|
|
2024-03-21 |
2024-03-19 |
S
Sale
|
McCarthy Sean A.
CEO
Executive Director
|
20,223
-3.7%
2.09
USD 42,175
|
20,223
-3.7%
|
2.09
|
USD 42,175
|
|
|
2024-03-21 |
2024-03-19 |
S
Sale
|
Ogden Christopher
SVP, Finance and Accounting
Officer
|
2,971
-3.4%
2.09
USD 6,196
|
2,971
-3.4%
|
2.09
|
USD 6,196
|
|
|
2023-12-22 |
2023-12-20 |
S
Sale
|
Ogden Christopher
SVP, Finance and Accounting
Officer
|
1,990
-3.9%
1.38
USD 2,747
|
1,990
-3.9%
|
1.38
|
USD 2,747
|
|
|
2023-12-22 |
2023-12-20 |
S
Sale
|
McCarthy Sean A.
CEO
Executive Director
|
13,551
-2.9%
1.38
USD 18,710
|
13,551
-2.9%
|
1.38
|
USD 18,710
|
|
|
2023-12-22 |
2023-12-20 |
S
Sale
|
Landau Jeffrey B
Chief Business Officer
Officer
|
4,077
-4.5%
1.38
USD 5,628
|
4,077
-4.5%
|
1.38
|
USD 5,628
|
|
|
2023-12-22 |
2023-12-20 |
S
Sale
|
ROWLAND LLOYD A
General Counsel
Officer
|
4,077
-4.0%
1.38
USD 5,629
|
4,077
-4.0%
|
1.38
|
USD 5,629
|
|
|
2023-12-22 |
2023-12-20 |
S
Sale
|
BELVIN MARCIA
SVP, Chief Scientific Officer
Officer
|
4,077
-2.6%
1.38
USD 5,628
|
4,077
-2.6%
|
1.38
|
USD 5,628
|
|
|
2023-09-22 |
2023-09-22 |
S
Sale
|
ROWLAND LLOYD A
General Counsel
Officer
|
5,486
-6.4%
1.30
USD 7,135
|
5,486
-6.4%
|
1.30
|
USD 7,135
|
|
|
2023-09-22 |
2023-09-22 |
S
Sale
|
Landau Jeffrey B
Chief Business Officer
Officer
|
4,119
-5.1%
1.30
USD 5,356
|
4,119
-5.1%
|
1.30
|
USD 5,356
|
|
|
2023-09-22 |
2023-09-22 |
S
Sale
|
McCarthy Sean A.
CEO
Executive Director
|
14,601
-3.3%
1.30
USD 18,987
|
14,601
-3.3%
|
1.30
|
USD 18,987
|
|
|
2023-09-22 |
2023-09-22 |
S
Sale
|
BELVIN MARCIA
SVP, Chief Scientific Officer
Officer
|
4,119
-2.7%
1.30
USD 5,356
|
4,119
-2.7%
|
1.30
|
USD 5,356
|
|
|
2023-03-20 |
2023-03-16 |
S
Sale
|
Landau Jeffrey B
Chief Financial Officer
Officer
|
1,477
-2.1%
1.98
USD 2,923
|
1,477
-2.1%
|
1.98
|
USD 2,923
|
|
|
2023-03-20 |
2023-03-16 |
S
Sale
|
ROWLAND LLOYD A
General Counsel
Officer
|
2,037
-2.8%
1.98
USD 4,031
|
2,037
-2.8%
|
1.98
|
USD 4,031
|
|
|
2023-03-20 |
2023-03-16 |
S
Sale
|
McCarthy Sean A.
CEO
Executive Director
|
7,121
-1.8%
1.88
USD 13,391
|
7,121
-1.8%
|
1.88
|
USD 13,391
|
|
|
2023-03-20 |
2023-03-16 |
S
Sale
|
Campoy Carlos
Chief Financial Officer
Officer
|
1,748
-4.4%
1.98
USD 3,459
|
1,748
-4.4%
|
1.98
|
USD 3,459
|
|
|
2023-03-20 |
2023-03-16 |
S
Sale
|
Peterson Amy C.
EVP, Chief Development Officer
Officer
|
4,257
-6.8%
1.98
USD 8,425
|
4,257
-6.8%
|
1.98
|
USD 8,425
|
|
|
2023-03-20 |
2023-03-16 |
S
Sale
|
Ogden Christopher
SVP, Finance and Accounting
Officer
|
516
-1.3%
1.98
USD 1,021
|
516
-1.3%
|
1.98
|
USD 1,021
|
|
|
2022-07-21 |
2022-07-20 |
S
Sale
|
Landau Jeffrey B
Chief Business Officer
Officer
|
4,206
-12.0%
1.42
USD 5,982
|
4,206
-12.0%
|
1.42
|
USD 5,982
|
|
|
2022-07-21 |
2022-07-20 |
S
Sale
|
Peterson Amy C.
EVP, Chief Development Officer
Officer
|
7,463
-10.6%
1.42
USD 10,612
|
7,463
-10.6%
|
1.42
|
USD 10,612
|
|
|
2022-07-21 |
2022-07-20 |
S
Sale
|
HANNAH ALISON L.
Chief Medical Officer
Officer
|
5,602
-14.9%
1.42
USD 7,965
|
5,602
-14.9%
|
1.42
|
USD 7,965
|
|
|
2022-07-21 |
2022-07-20 |
S
Sale
|
Campoy Carlos
Chief Financial Officer
Officer
|
3,949
-9.0%
1.42
USD 5,617
|
3,949
-9.0%
|
1.42
|
USD 5,617
|
|
|
2022-07-21 |
2022-07-20 |
S
Sale
|
ROWLAND LLOYD A
General Counsel
Officer
|
5,602
-11.4%
1.42
USD 7,968
|
5,602
-11.4%
|
1.42
|
USD 7,968
|
|
|
2022-07-21 |
2022-07-20 |
S
Sale
|
McCarthy Sean A.
President and CEO
Executive Director
|
14,911
-4.9%
1.42
USD 21,206
|
14,911
-4.9%
|
1.42
|
USD 21,206
|
|
|
2021-06-21 |
2021-06-16 |
PS
Planned sale
|
McCarthy Sean A.
President and CEO
Executive Director
|
100,000
-51.8%
7.04
USD 704,470
|
100,000
-51.8%
|
7.04
|
USD 704,470
|
|
|
2021-04-02 |
2021-03-31 |
PS
Planned sale
|
McCarthy Sean A.
President and CEO
Executive Director
|
100,000
-32.6%
7.49
USD 749,470
|
100,000
-32.6%
|
7.49
|
USD 749,470
|
|
|
2020-05-14 |
2020-05-12 |
PS
Planned sale
|
McCarthy Sean A.
President and CEO
Executive Director
|
36,000
-29.9%
15.00
USD 540,000
|
36,000
-29.9%
|
15.00
|
USD 540,000
|
|
|
2019-03-05 |
2019-03-04 |
B
Purchase
|
ROWLAND LLOYD A
General Counsel
Officer
|
9,000
+919.3%
10.33
USD 92,970
|
9,000
+919.3%
|
10.33
|
USD 92,970
|
|
|
2018-12-14 |
2018-12-12 |
PS
Planned sale
|
RAY DEBANJAN
Chief Financial Officer
Officer
|
3,000
-33.6%
15.00
USD 45,000
|
3,000
-33.6%
|
15.00
|
USD 45,000
|
|
|
2018-11-05 |
2018-11-02 |
PS
Planned sale
|
McCarthy Sean A.
President and CEO
Executive Director
|
1,156
-1.4%
15.01
USD 17,348
|
1,156
-1.4%
|
15.01
|
USD 17,348
|
|
|
2018-11-05 |
2018-11-01 |
PS
Planned sale
|
McCarthy Sean A.
President and CEO
Executive Director
|
5,270
-6.0%
15.00
USD 79,050
|
5,270
-6.0%
|
15.00
|
USD 79,050
|
|
|
2018-11-05 |
2018-11-01 |
PS
Planned sale
|
McCarthy Sean A.
President and CEO
Executive Director
|
100
-0.1%
15.01
USD 1,501
|
100
-0.1%
|
15.01
|
USD 1,501
|
|
|
2018-11-05 |
2018-11-01 |
PS
Planned sale
|
RAY DEBANJAN
Chief Financial Officer
Officer
|
3,000
-33.6%
15.00
USD 45,000
|
3,000
-33.6%
|
15.00
|
USD 45,000
|
|
|
2018-10-02 |
2018-10-01 |
PS
Planned sale
|
RAY DEBANJAN
Chief Financial Officer
Officer
|
3,000
-33.6%
18.46
USD 55,380
|
3,000
-33.6%
|
18.46
|
USD 55,380
|
|
|
2018-09-06 |
2018-09-04 |
PS
Planned sale
|
McCarthy Sean A.
President and CEO
Executive Director
|
13,052
-13.7%
21.86
USD 285,343
|
13,052
-13.7%
|
21.86
|
USD 285,343
|
|
|
2018-09-06 |
2018-09-04 |
PS
Planned sale
|
RAY DEBANJAN
Chief Financial Officer
Officer
|
3,000
-33.6%
22.39
USD 67,170
|
3,000
-33.6%
|
22.39
|
USD 67,170
|
|
|
2018-08-02 |
2018-08-01 |
PS
Planned sale
|
RAY DEBANJAN
Chief Financial Officer
Officer
|
3,000
-33.6%
26.05
USD 78,150
|
3,000
-33.6%
|
26.05
|
USD 78,150
|
|
|
2018-07-09 |
2018-07-05 |
PS
Planned sale
|
McCarthy Sean A.
President and CEO
Executive Director
|
4,497
-5.2%
25.06
USD 112,689
|
4,497
-5.2%
|
25.06
|
USD 112,689
|
|
|
2018-07-06 |
2018-07-03 |
PS
Planned sale
|
McCarthy Sean A.
President and CEO
Executive Director
|
2,028
-2.4%
25.09
USD 50,880
|
2,028
-2.4%
|
25.09
|
USD 50,880
|
|
|
2018-07-03 |
2018-07-02 |
PS
Planned sale
|
McCarthy Sean A.
President and CEO
Executive Director
|
13,052
-13.7%
23.42
USD 305,708
|
13,052
-13.7%
|
23.42
|
USD 305,708
|
|
|
2018-07-03 |
2018-07-02 |
PS
Planned sale
|
RAY DEBANJAN
Chief Financial Officer
Officer
|
3,000
-33.6%
22.56
USD 67,680
|
3,000
-33.6%
|
22.56
|
USD 67,680
|
|
|
2018-06-05 |
2018-06-01 |
PS
Planned sale
|
RAY DEBANJAN
Chief Financial Officer
Officer
|
3,000
-33.6%
25.93
USD 77,793
|
3,000
-33.6%
|
25.93
|
USD 77,793
|
|
|
2018-05-02 |
2018-05-01 |
PS
Planned sale
|
McCarthy Sean A.
President and CEO
Executive Director
|
19,578
-80.8%
26.55
USD 519,743
|
19,578
-80.8%
|
26.55
|
USD 519,743
|
|
|
2018-05-02 |
2018-05-01 |
PS
Planned sale
|
RAY DEBANJAN
Chief Financial Officer
Officer
|
3,000
-38.8%
26.52
USD 79,562
|
3,000
-38.8%
|
26.52
|
USD 79,562
|
|
|
2018-04-04 |
2018-04-02 |
PS
Planned sale
|
RAY DEBANJAN
Chief Financial Officer
Officer
|
3,000
-38.8%
28.12
USD 84,360
|
3,000
-38.8%
|
28.12
|
USD 84,360
|
|
|
2018-03-27 |
2018-03-26 |
PS
Planned sale
|
GLUCK FREDERICK W
|
5,000
-1.8%
31.93
USD 159,642
|
5,000
-1.8%
|
31.93
|
USD 159,642
|
|
|
2018-03-05 |
2018-03-02 |
PS
Planned sale
|
GLUCK FREDERICK W
|
16,181
-5.5%
30.00
USD 485,466
|
16,181
-5.5%
|
30.00
|
USD 485,466
|
|
|
2018-03-05 |
2018-03-02 |
PS
Planned sale
|
HUMPHREY RACHEL
Chief Medical Officer
|
16,160
-34.8%
30.00
USD 484,800
|
16,160
-34.8%
|
30.00
|
USD 484,800
|
|
|
2018-03-05 |
2018-03-02 |
PS
Planned sale
|
RAY DEBANJAN
Chief Financial Officer
|
1,944
-29.1%
31.02
USD 60,293
|
1,944
-29.1%
|
31.02
|
USD 60,293
|
|
|
2018-03-05 |
2018-03-02 |
PS
Planned sale
|
RAY DEBANJAN
Chief Financial Officer
|
12,541
-65.2%
30.41
USD 381,384
|
12,541
-65.2%
|
30.41
|
USD 381,384
|
|
|
2018-03-05 |
2018-03-02 |
PS
Planned sale
|
RAY DEBANJAN
Chief Financial Officer
|
5,515
-53.8%
30.06
USD 165,775
|
5,515
-53.8%
|
30.06
|
USD 165,775
|
|
|
2018-03-05 |
2018-03-01 |
PS
Planned sale
|
McCarthy Sean A.
President and CEO
Executive Director
|
19,578
-80.8%
29.43
USD 576,141
|
19,578
-80.8%
|
29.43
|
USD 576,141
|
|
|
2018-03-05 |
2018-03-01 |
PS
Planned sale
|
RAY DEBANJAN
Chief Financial Officer
|
13,000
-73.3%
29.40
USD 382,242
|
13,000
-73.3%
|
29.40
|
USD 382,242
|
|
|
2018-03-02 |
2018-02-28 |
PS
Planned sale
|
GLUCK FREDERICK W
|
3,819
-1.3%
30.00
USD 114,570
|
3,819
-1.3%
|
30.00
|
USD 114,570
|
|
|
2018-03-02 |
2018-02-28 |
PS
Planned sale
|
HUMPHREY RACHEL
Chief Medical Officer
|
23,840
-44.1%
30.00
USD 715,200
|
23,840
-44.1%
|
30.00
|
USD 715,200
|
|
|
2018-02-02 |
2018-02-01 |
PS
Planned sale
|
RAY DEBANJAN
Chief Financial Officer
Officer
|
2,548
-35.0%
26.69
USD 68,010
|
2,548
-35.0%
|
26.69
|
USD 68,010
|
|
|
2018-01-09 |
2018-01-05 |
PS
Planned sale
|
McCarthy Sean A.
President and CEO
Executive Director
|
6,526
-58.4%
25.01
USD 163,215
|
6,526
-58.4%
|
25.01
|
USD 163,215
|
|
|
2018-01-08 |
2018-01-05 |
PS
Planned sale
|
GLUCK FREDERICK W
Non-Executive Director
|
10,000
-3.3%
25.01
USD 250,078
|
10,000
-3.3%
|
25.01
|
USD 250,078
|
|
|
2018-01-04 |
2018-01-02 |
PS
Planned sale
|
McCarthy Sean A.
President and CEO
Executive Director
|
13,052
-73.8%
21.04
USD 274,614
|
13,052
-73.8%
|
21.04
|
USD 274,614
|
|
|
2018-01-03 |
2018-01-02 |
PS
Planned sale
|
RAY DEBANJAN
Chief Financial Officer
Officer
|
2,500
-25.5%
21.11
USD 52,775
|
2,500
-25.5%
|
21.11
|
USD 52,775
|
|
|
2017-12-28 |
2017-12-26 |
PS
Planned sale
|
GLUCK FREDERICK W
|
5,000
-1.6%
22.29
USD 111,426
|
5,000
-1.6%
|
22.29
|
USD 111,426
|
|
|
2017-12-05 |
2017-12-01 |
PS
Planned sale
|
RAY DEBANJAN
Chief Financial Officer
|
2,500
-20.3%
20.58
USD 51,450
|
2,500
-20.3%
|
20.58
|
USD 51,450
|
|
|
2017-12-05 |
2017-12-01 |
PS
Planned sale
|
McCarthy Sean A.
President and CEO
Executive Director
|
14,340
-75.5%
20.60
USD 295,404
|
14,340
-75.5%
|
20.60
|
USD 295,404
|
|
